Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report. Issue 4 (27th January 2023)
- Record Type:
- Journal Article
- Title:
- Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report. Issue 4 (27th January 2023)
- Main Title:
- Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report
- Authors:
- Li, Ruizhao
Dong, Wei
Chen, Yingwen
Tang, Tianwei
Zhao, Xingchen
Zhang, Li
Liang, Xinling - Abstract:
- Abstract : Rationale: Focal segmental glomerulosclerosis (FSGS) describes a renal histologic lesion with diverse causes and pathogenicities. Monogenic abnormalities which are associated with impaired function of podocyte could result in FSGS. Most of genetic FSGS do not respond to immunosuppressive agents and often develop end-stage kidney disease. We reported a case of FSGS caused by myosin1e (MYO1E) mutation, alleviated by cyclosporine A (CsA) and low-dose glucocorticoid. Patient concerns: The patient was a 38-year-old male with nephrotic range proteinuria. He didn't respond to prednisone 65mg/day. Kidney biopsy in our hospital showed FSGS with several hypoplasia and tiny loops. In addition, focal thickening and disorganization of the glomerular gasement membrane as well as diffuse foot process effacement were observed in electron microscope. Diagnoses: Genetic testing indicated homozygous deletion mutation of MYO1E. The patient was diagnosed with genetic FSGS caused by MYO1E homozygous mutation. Interventions: The patient was treated with CsA 50mg twice a day and low-dose methylprednisolone. Outcomes: CsA and low-dose glucocorticoid dramatically reduced proteinuria, and partial remission was attained in 3 years follow-up. Lessons: MYO1E autosomal recessive mutation was a rare FSGS causative mutation that might benefit from CsA treatment. However, the long-term effect of CsA on FSGS caused by this mutation should be investigated in the future.
- Is Part Of:
- Medicine. Volume 102:Issue 4(2023)
- Journal:
- Medicine
- Issue:
- Volume 102:Issue 4(2023)
- Issue Display:
- Volume 102, Issue 4 (2023)
- Year:
- 2023
- Volume:
- 102
- Issue:
- 4
- Issue Sort Value:
- 2023-0102-0004-0000
- Page Start:
- e32683
- Page End:
- Publication Date:
- 2023-01-27
- Subjects:
- focal segmental glomerulosclerosis -- myosin 1e -- cyclosporine A
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000032683 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25479.xml